Cargando…

Molecular action of sulphonylureas on K(ATP) channels: a real partnership between drugs and nucleotides

Sulphonylureas stimulate insulin secretion from pancreatic β-cells primarily by closing ATP-sensitive K(+) channels in the β-cell plasma membrane. The mechanism of channel inhibition by these drugs is unusually complex. As direct inhibitors of channel activity, sulphonylureas act only as partial ant...

Descripción completa

Detalles Bibliográficos
Autores principales: de Wet, Heidi, Proks, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613533/
https://www.ncbi.nlm.nih.gov/pubmed/26517901
http://dx.doi.org/10.1042/BST20150096
_version_ 1782396292026073088
author de Wet, Heidi
Proks, Peter
author_facet de Wet, Heidi
Proks, Peter
author_sort de Wet, Heidi
collection PubMed
description Sulphonylureas stimulate insulin secretion from pancreatic β-cells primarily by closing ATP-sensitive K(+) channels in the β-cell plasma membrane. The mechanism of channel inhibition by these drugs is unusually complex. As direct inhibitors of channel activity, sulphonylureas act only as partial antagonists at therapeutic concentrations. However, they also exert an additional indirect inhibitory effect via modulation of nucleotide-dependent channel gating. In this review, we summarize current knowledge and recent advances in our understanding of the molecular mechanism of action of these drugs.
format Online
Article
Text
id pubmed-4613533
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-46135332015-10-23 Molecular action of sulphonylureas on K(ATP) channels: a real partnership between drugs and nucleotides de Wet, Heidi Proks, Peter Biochem Soc Trans Biochemical Society Focused Meetings Sulphonylureas stimulate insulin secretion from pancreatic β-cells primarily by closing ATP-sensitive K(+) channels in the β-cell plasma membrane. The mechanism of channel inhibition by these drugs is unusually complex. As direct inhibitors of channel activity, sulphonylureas act only as partial antagonists at therapeutic concentrations. However, they also exert an additional indirect inhibitory effect via modulation of nucleotide-dependent channel gating. In this review, we summarize current knowledge and recent advances in our understanding of the molecular mechanism of action of these drugs. Portland Press Ltd. 2015-10-09 2015-10-01 /pmc/articles/PMC4613533/ /pubmed/26517901 http://dx.doi.org/10.1042/BST20150096 Text en © 2015 Authors; published by Portland Press Limited
spellingShingle Biochemical Society Focused Meetings
de Wet, Heidi
Proks, Peter
Molecular action of sulphonylureas on K(ATP) channels: a real partnership between drugs and nucleotides
title Molecular action of sulphonylureas on K(ATP) channels: a real partnership between drugs and nucleotides
title_full Molecular action of sulphonylureas on K(ATP) channels: a real partnership between drugs and nucleotides
title_fullStr Molecular action of sulphonylureas on K(ATP) channels: a real partnership between drugs and nucleotides
title_full_unstemmed Molecular action of sulphonylureas on K(ATP) channels: a real partnership between drugs and nucleotides
title_short Molecular action of sulphonylureas on K(ATP) channels: a real partnership between drugs and nucleotides
title_sort molecular action of sulphonylureas on k(atp) channels: a real partnership between drugs and nucleotides
topic Biochemical Society Focused Meetings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613533/
https://www.ncbi.nlm.nih.gov/pubmed/26517901
http://dx.doi.org/10.1042/BST20150096
work_keys_str_mv AT dewetheidi molecularactionofsulphonylureasonkatpchannelsarealpartnershipbetweendrugsandnucleotides
AT prokspeter molecularactionofsulphonylureasonkatpchannelsarealpartnershipbetweendrugsandnucleotides